What is Enthea?
Enthea is at the forefront of addressing the escalating mental health crisis by facilitating employer-funded access to novel therapeutic treatments. The company's core mission is to democratize access to psychedelic-assisted therapies, making them affordable, accessible, and equitable for a broad population, not just the affluent. Through its comprehensive Provider Network, Enthea offers a seamless, turn-key solution for employers to integrate these advanced treatments into their healthcare coverage for employees and their families, thereby expanding the reach of potentially life-changing therapies.
How much funding has Enthea raised?
Enthea has raised a total of $2M across 1 funding round:
Angel/Seed
$2M
Angel/Seed (2022): $2M with participation from Tabula Rasa Ventures
Key Investors in Enthea
Tabula Rasa Ventures
Tabula Rasa Ventures is a prominent financial investment firm dedicated to fostering the next generation of health innovation. The firm invests in early-stage startups across various sectors, including drug development, healthcare infrastructure, and technology, providing both capital and hands-on support.
What's next for Enthea?
With this substantial enterprise-level funding, Enthea is strategically positioned to scale its operations and further penetrate the employer benefits market. The recent strategic investment signals a pivotal moment for the company, likely enabling expansion of its Provider Network, enhancement of its technological infrastructure for seamless integration, and increased outreach to corporate partners. This capital infusion is expected to accelerate Enthea's mission to make psychedelic-assisted therapies a mainstream component of employer-sponsored healthcare, driving significant growth and impact in the mental wellness sector.
See full Enthea company page
